Doctor profile · Federal record
Dr. JASON SALGANICK, MD
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · PHOENIX, AZ
- NPI 1124125174
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11209 N TATUM BLVD, SUITE 260
PHOENIX, AZ 850286025
(602) 494-6800
fax (602) 494-6803 - Mailing address
-
PO BOX 6423
CHANDLER, AZ 852466423
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- November 14, 2022
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Arizona #37292
- Medicaid
- AZ #280343
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124125174. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,770
Distinct HCPCS
10
Medicare allowed
$195,870
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 22,500 | 18 | $1 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,614 | 18 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,064 | 14 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 740 | 15 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 597 | 278 | $87 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 289 | 35 | $28 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 275 | 53 | $124 | |
96372 |
Injection of drug or substance under skin or into muscle | 230 | 45 | $14 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 195 | 162 | $54 | |
96375 |
Injection of additional new drug or substance into vein | 180 | 28 | $15 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 977. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$211,030
Transactions
301
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SOBI, INC | 55 | $83,571.93 | |
| Incyte Corporation | 94 | $58,495.58 | |
| GlaxoSmithKline, LLC. | 32 | $31,732.97 | |
| AstraZeneca Pharmaceuticals LP | 31 | $21,618.57 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $4,309.59 | |
| ADC Therapeutics America, Inc. | 3 | $2,445.43 | |
| Ipsen Biopharmaceuticals, Inc | 4 | $2,263.41 | |
| Genmab U.S., Inc. | 5 | $1,859.26 | |
| TAIHO ONCOLOGY, INC. | 2 | $1,129.22 | |
| BeiGene USA, Inc. | 5 | $765.09 | |
| Novartis Pharmaceuticals Corporation | 12 | $356.59 | |
| ABBVIE INC. | 18 | $308.34 | |
| PFIZER INC. | 15 | $276.23 | |
| Alexion Pharmaceuticals, Inc. | 6 | $218.04 | |
| Karyopharm Therapeutics Inc. | 5 | $202.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
606
Patients
200
Total drug cost
$97,550
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 87 | 19 | $1,103 |
| Letrozole | Generic | 68 | 18 | $1,489 |
| Xarelto (Rivaroxaban) | Brand | 60 | 15 | $48,977 |
| Prochlorperazine Maleate | Generic | 54 | 35 | $1,463 |
| Eliquis (Apixaban) | Brand | 45 | 0 | $32,586 |
| Dexamethasone | Generic | 44 | 23 | $642 |
| Ondansetron Odt (Ondansetron) | Brand | 42 | 30 | $1,056 |
| Prednisone | Generic | 38 | 11 | $225 |
| Hydroxyurea | Generic | 33 | 0 | $881 |
| Olanzapine | Generic | 32 | 15 | $217 |